All times are listed in CEST (Central European Summer Time)

Displaying One Session

View
Controversy session

Enhanced androgen signalling inhibition should be the treatment of choice for treatment of mCSPC rather than docetaxel

Date
Mon, 20.09.2021
Time
13:30 - 14:05
Location
Channel 6
Chairs
  • Eleni Efstathiou (Houston, TX, United States of America)
Controversy session

Introduction by the chair

Speakers
  • Eleni Efstathiou (Houston, TX, United States of America)
Lecture Time
13:30 - 13:33
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 20.09.2021
Time
13:30 - 14:05
Controversy session

Polling 1 (led by chair)

Speakers
  • Eleni Efstathiou (Houston, TX, United States of America)
Lecture Time
13:33 - 13:34
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 20.09.2021
Time
13:30 - 14:05
Controversy session

Yes

Speakers
  • Karim Fizazi (Villejuif, Cedex, France)
Lecture Time
13:34 - 13:44
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 20.09.2021
Time
13:30 - 14:05
Controversy session

No

Speakers
  • Ronald De Wit (Rotterdam, Netherlands)
Lecture Time
13:44 - 13:54
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 20.09.2021
Time
13:30 - 14:05
Controversy session

Polling 2 (led by chair)

Speakers
  • Eleni Efstathiou (Houston, TX, United States of America)
Lecture Time
13:54 - 13:55
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 20.09.2021
Time
13:30 - 14:05
Controversy session

Q&A

Lecture Time
13:55 - 14:05
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 20.09.2021
Time
13:30 - 14:05